Across the recent three months, 4 analysts have shared their insights on Zoetis (NYSE:ZTS), expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick ...
16 analysts have expressed a variety of opinions on Fortinet FTNT over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of ...
Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Celldex Therapeutics (NASDAQ:CLDX) in the last three months. The following table summarizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback